PDCD1 and cancer: Over the past 10 years, a great deal of work has been done to better understand that role, with the development of therapies such as programmed cell death protein 1 (PD‐1)/programmed death ligand 1 (PD‐L1) inhibitors, cancer vaccines and adoptive cell therapy.